| Scientific publications by Santaris Pharma in 2007 |
| |
Protein kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
Frankel LB, Lykkesfeldt AE, Hansen JB and Stenvang J
Breast Cancer Res Treat 2007 104(2): 165-179 |
|
miR-200b mediates post-transcriptional repression of ZFHX1B
Christoffersen NR, Silahtaroglu A, Orom UA, Kauppinen S and Lund AH RNA 2007 13(8):1172-1178 |
|
Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A3 receptor ligands
Ravn J , Qvortrup K, Rosenbohm C and Koch T
Bioorg Med Chem 2007 15(16): 5440-5447 |
|
Locked Nucleic Acid
Koch T and Orum H
Antisense Drug Technology; principles, strategies and applications ST Crooke ed Taylor & Francis Group 2007 2nd ed: 519-564. |
|
Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using Locked Nucleic Acid probes abd tyramide signal amplification
Silahtaroglu AN , Nolting D, Dyrskjot L, Berezikov E , Moller M, Tommerup N and Kauppinen S
Nat Protoc 2007 2(10): 2520-2528 |
|
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
Sempere LF, Christensen M, Silahtaroglu A, Bak M , Heath CV, Schwartz G, Wells W, Kauppinen S and Cole CN
Cancer Res 2007 67:11612 - 20 |
|
Survivin mRNA antagonists using locked nucleic Acid, potential for molecular cancer therapy
Fisker N, Westergaard M, Hansen HF, Hansen JB
Nucleosides Nucleotides Nucleic Acids 2007 26(10): 1427-1430 |
|
|
| |
|
